OneMedNet Corp (ONMD) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
TRIDENT COURT, 1 OAKCROFT ROAD SURREY, KT9 1BD |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 31 | 453 | |||
| Cash and cash equivalents | 31 | 453 | |||
| Receivables | |||||
| Prepaid expense | 21 | ||||
| Other undisclosed current assets | 62 | ||||
| Total current assets: | 31 | 536 | |||
| Noncurrent Assets | |||||
| Property, plant and equipment | |||||
| Asset, held-in-trust | 29,029 | 117,321 | |||
| Total noncurrent assets: | 29,029 | 117,321 | |||
| TOTAL ASSETS: | 29,060 | 117,857 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities, including: | 285 | 164 | |||
| Taxes payable | ✕ | ✕ | 164 | ||
| Accrued liabilities | 285 | ||||
| Other undisclosed accounts payable and accrued liabilities | |||||
| Deferred revenue | |||||
| Debt | |||||
| Due to related parties | ✕ | 12 | |||
| Other undisclosed current liabilities | 1,680 | 126 | |||
| Total current liabilities: | 1,976 | 290 | |||
| Noncurrent Liabilities | |||||
| Liabilities, other than long-term debt | 207 | ||||
| Due to related parties | ✕ | 207 | |||
| Other undisclosed noncurrent liabilities | 6,933 | 8,877 | |||
| Total noncurrent liabilities: | 7,140 | 8,877 | |||
| Total liabilities: | 9,117 | 9,167 | |||
| Temporary equity, carrying amount | 117,300 | ||||
| Equity | |||||
| Equity, attributable to parent, including: | (8,806) | (8,609) | |||
| Common stock | |||||
| Additional paid in capital | 2,826 | ||||
| Accumulated deficit | (11,633) | (8,610) | |||
| Other undisclosed equity, attributable to parent | 0 | 0 | |||
| Other undisclosed equity | 28,750 | ||||
| Total equity: | 19,944 | (8,609) | |||
| TOTAL LIABILITIES AND EQUITY: | 29,060 | 117,857 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|
| Revenues | ||||
| Cost of revenue | ||||
| Gross profit: | ||||
| Operating expenses | (5,104) | (421) | ||
| Other undisclosed operating loss | (206) | (164) | ||
| Operating loss: | (5,309) | (585) | ||
| Nonoperating income (expense) | 2 | |||
| Investment income, nonoperating | 2 | |||
| Interest and debt expense | ||||
| Loss from continuing operations before equity method investments, income taxes: | (5,309) | (584) | ||
| Other undisclosed income from continuing operations before income taxes | 5,861 | |||
| Income (loss) from continuing operations before income taxes: | 552 | (584) | ||
| Income tax expense (benefit) | (215) | 119 | ||
| Income (loss) from continuing operations: | 337 | (465) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (465) | |
| Other undisclosed net income | 5,601 | |||
| Net income (loss): | 337 | 5,136 | ||
| Other undisclosed net income attributable to parent | ||||
| Net income (loss) available to common stockholders, diluted: | 337 | 5,136 | ||
Comprehensive Income ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|
| Net income (loss): | 337 | 5,136 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 337 | 5,136 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.